Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel L-glutamic acid route for multi-chiral tetrahydrofuran rings. High stereoselectivity and mild conditions for cost-effective API manufacturing.
Patent CN101362710A details a clean catalytic hydrogenation route for aminobenzenesulfonic acid, offering superior purity and eliminating iron mud waste for dye intermediates.
Patent CN102391243A details a novel 7-step synthesis for Atorvastatin intermediates, eliminating expensive lithium reagents and improving supply chain reliability.
Patent CN111349014A reveals a safer, high-yield route for Methyl (methylamino)squarate, eliminating hazardous solvents and reducing manufacturing costs for global supply chains.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.
Novel 5-step synthesis from D-Glutamic acid for DPP-IV inhibitors. High yield, mild conditions, and cost-effective industrial manufacturing process.
Discover the novel radical coupling synthesis of octadecanedioic acid (CN112079708A). Achieve >98.5% purity with mild conditions, offering significant cost reduction and supply reliability for polymer applications.
Patent CN112079708A reveals a mild radical coupling route for octadecanedioic acid. Achieve >98.5% purity with reduced costs for polymer and pharma applications.
Patent CN116120325B reveals a novel preparation method for Ketorolac EP Impurity D with high purity and simplified operations for reliable pharmaceutical intermediates supply chains.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patented chloroform-based route for o-chloromandelic acid ensures high purity and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN114702487B details a novel butanol extraction method for lysergic acid, offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104592178B details one-step synthesis. Offers high purity and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Novel synthesis route for high-purity pharmaceutical intermediates. Safe scale-up and cost reduction for global supply chains ensuring reliable procurement.
Advanced phase-transfer catalysis patent CN101096362A analysis. High-purity AE-active ester production with optimized supply chain reliability and cost efficiency.
Patent CN1377337A details a novel route for COX-2 inhibitor intermediates via lactam hydrolysis. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN121085987A reveals scalable synthesis for 5 beta-carp cholesterol sulfate. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110903240A reveals a mild ester-hydrolysis route for cabozantinib, offering high purity and reduced environmental impact for pharmaceutical intermediate manufacturing.
Novel synthesis route for Baculiferin L intermediate. Cost-effective, scalable, high-purity pharmaceutical intermediate manufacturing process.
Novel malic acid route offers cost reduction and scalable production for high-purity 6-hydroxynicotinic acid intermediates.